|
1
|
Chekler ELP, Unwalla R, Khan TA, Tangirala RS, Johnson M, St. Andre M, Anderson JT, Kenney T, Chiparri S, McNally C, Kilbourne E, Thompson C, Nagpal S, Weber G, Schelling S, Owens J, Morris CA, Powell D, Verhoest PR, Gilbert AM. 1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile Derivatives as Potent and Tissue Selective Androgen Receptor Modulators. J Med Chem 2014; 57:2462-71. [DOI: 10.1021/jm401625b] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Eugene L. Piatnitski Chekler
- BioTherapeutics Medicinal
Chemistry, Pfizer Global Research and Development, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - Rayomond Unwalla
- BioTherapeutics Medicinal
Chemistry, Pfizer Global Research and Development, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - Taukeer A. Khan
- BioTherapeutics Medicinal
Chemistry, Pfizer Global Research and Development, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - Raghuram S. Tangirala
- BioTherapeutics Medicinal
Chemistry, Pfizer Global Research and Development, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - Mark Johnson
- BioTherapeutics Medicinal
Chemistry, Pfizer Global Research and Development, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - Michael St. Andre
- BioTherapeutics Medicinal
Chemistry, Pfizer Global Research and Development, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - James T. Anderson
- BioTherapeutics Medicinal
Chemistry, Pfizer Global Research and Development, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - Thomas Kenney
- BioTherapeutics Medicinal
Chemistry, Pfizer Global Research and Development, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - Sue Chiparri
- BioTherapeutics Medicinal
Chemistry, Pfizer Global Research and Development, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - Chris McNally
- BioTherapeutics Medicinal
Chemistry, Pfizer Global Research and Development, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - Edward Kilbourne
- BioTherapeutics Medicinal
Chemistry, Pfizer Global Research and Development, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - Catherine Thompson
- BioTherapeutics Medicinal
Chemistry, Pfizer Global Research and Development, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - Sunil Nagpal
- BioTherapeutics Medicinal
Chemistry, Pfizer Global Research and Development, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - Gregory Weber
- BioTherapeutics Medicinal
Chemistry, Pfizer Global Research and Development, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - Scott Schelling
- BioTherapeutics Medicinal
Chemistry, Pfizer Global Research and Development, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - Jane Owens
- BioTherapeutics Medicinal
Chemistry, Pfizer Global Research and Development, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - Carl A. Morris
- BioTherapeutics Medicinal
Chemistry, Pfizer Global Research and Development, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - Dennis Powell
- BioTherapeutics Medicinal
Chemistry, Pfizer Global Research and Development, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - Patrick R. Verhoest
- BioTherapeutics Medicinal
Chemistry, Pfizer Global Research and Development, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - Adam M. Gilbert
- BioTherapeutics Medicinal
Chemistry, Pfizer Global Research and Development, 200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| |
Collapse
|